Dicusat E en es it fr

Dicusat E Brand names, Dicusat E Analogs

Dicusat E Brand Names Mixture

  • No information avaliable

Dicusat E Chemical_Formula


Dicusat E RX_link


Dicusat E fda sheet

Dicusat_E FDA

Dicusat E msds (material safety sheet)

Dicusat_E MSDS

Dicusat E Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

Dicusat E Molecular Weight

308.328 g/mol

Dicusat E Melting Point

161 oC

Dicusat E H2O Solubility

17 mg/L

Dicusat E State


Dicusat E LogP


Dicusat E Dosage Forms

Powder for solution; Tablet

Dicusat E Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

Dicusat E Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

Dicusat E Absorption

No information avaliable

Dicusat E side effects and Toxicity

LD50=374 (orally in mice)

Dicusat E Patient Information

No information avaliable

Dicusat E Organisms Affected

Humans and other mammals